Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Heba N Altarawneh"'
Autor:
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, Mohammad R. Hasan, Hadi M. Yassine, Hebah A. Al-Khatib, Asmaa A. Al Thani, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A. Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J. Abu-Raddad
Publikováno v:
EBioMedicine, Vol 95, Iss , Pp 104734- (2023)
Summary: Background: Protection against SARS-CoV-2 symptomatic infection and severe COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination, and hybrid immunity of previous infection and vaccination were investigated in
Externí odkaz:
https://doaj.org/article/ac53db5b2dbd49bbbf0a3f0d76d82d3b
Autor:
Hiam Chemaitelly, Patrick Tang, Peter Coyle, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Mohammad R. Hasan, Houssein H. Ayoub, Heba N. Altarawneh, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed G. Al-Kuwari, Adeel A. Butt, Hamad E. Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J. Abu-Raddad
Publikováno v:
New England Journal of Medicine. 388:665-667
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77c58922a8637acf01e1fb76b4338933
https://doi.org/10.1056/nejmc2214114
https://doi.org/10.1056/nejmc2214114
Autor:
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, Mohammad R. Hasan, Hadi M. Yassine, Hebah A. Al-Khatib, Asmaa A. Al Thani, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A. Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J. Abu-Raddad
BackgroundProtection against SARS-CoV-2 symptomatic infection and severe COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination, and hybrid immunity of previous infection and vaccination were investigated in Qatar for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73f44ccda0cb88cad04bf8ef063bbeab
https://doi.org/10.1101/2023.04.21.23288917
https://doi.org/10.1101/2023.04.21.23288917
Autor:
Heba N Altarawneh, Hiam Chemaitelly, Houssein H Ayoub, Patrick Tang, Mohammad R Hasan, Hadi M Yassine, Hebah A Al-Khatib, Maria K Smatti, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F Abdul-Rahim, Gheyath K Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A Butt, Hamad Eid Al-Romaihi, Mohamed H Al-Thani, Abdul Latif Al Khal, Roberto Bertollini, Laith J Abu-Raddad
Publikováno v:
Open Forum Infectious Diseases. 9
Background Protection offered by five different forms of immunity, combining natural and vaccine immunity, was investigated against symptomatic SARS-CoV-2 infection from Omicron BA.1 or BA.2, and severe, critical, or fatal COVID-19 from BA.1 or BA.2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cf035bfe8c85b8b268848a7b180ef3c
https://doi.org/10.1093/ofid/ofac492.1591
https://doi.org/10.1093/ofid/ofac492.1591
Autor:
Hiam Chemaitelly, Patrick Tang, Peter Coyle, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Mohammad R. Hasan, Houssein H. Ayoub, Heba N. Altarawneh, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed G. Al-Kuwari, Adeel A. Butt, Hamad E. Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J. Abu-Raddad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b2517923bb50ef7fc557b2bbed8c18d
https://doi.org/10.1101/2022.10.29.22281606
https://doi.org/10.1101/2022.10.29.22281606
Autor:
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, Mohammad R. Hasan, Peter Coyle, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed G. Al-Kuwari, Adeel A. Butt, Hamad E. Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Patrick Tang, Laith J. Abu-Raddad
Publikováno v:
The New England journal of medicine. 387(17)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1346162eee05a04aaa6f3ed4a3b73f64
https://pubmed.ncbi.nlm.nih.gov/36198139
https://pubmed.ncbi.nlm.nih.gov/36198139
Autor:
Heba N. Altarawneh, Hiam Chemaitelly, Mohammad R. Hasan, Houssein H. Ayoub, Suelen Qassim, Sawsan AlMukdad, Peter Coyle, Hadi M. Yassine, Hebah A. Al-Khatib, Fatiha M. Benslimane, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed G. Al-Kuwari, Adeel A. Butt, Hamad E. Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Patrick Tang, Laith J. Abu-Raddad
Publikováno v:
New England Journal of Medicine. 386:1288-1290
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e537205781b25444f8ac538021b845b4
https://doi.org/10.1056/nejmc2200133
https://doi.org/10.1056/nejmc2200133
Autor:
Hiam Chemaitelly, Sawsan AlMukdad, Houssein H. Ayoub, Heba N. Altarawneh, Peter Coyle, Patrick Tang, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Mohammad R. Hasan, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Hamad Eid Al-Romaihi, Adeel A. Butt, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J. Abu-Raddad
BackgroundThe BNT162b2 COVID-19 vaccine is authorized for children 5-11 years of age and adolescents 12-17 years of age, but in different dose sizes. We assessed BNT162b2 real-world effectiveness against SARS-CoV-2 infection among children and adoles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6faa1e5e269fbc9f0e3a10d7ca899174
https://doi.org/10.1101/2022.07.26.22278045
https://doi.org/10.1101/2022.07.26.22278045
Autor:
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, Mohammad R. Hasan, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed G. Al-Kuwari, Adeel A. Butt, Hamad E. Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J. Abu-Raddad
Publikováno v:
The New England journal of medicine. 387(1)
The protection conferred by natural immunity, vaccination, and both against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the BA.1 or BA.2 sublineages of the omicron (B.1.1.529) variant is unclear. We conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f7a3bcabc8756ecaaaf5cf6274c1be
https://pubmed.ncbi.nlm.nih.gov/35704396
https://pubmed.ncbi.nlm.nih.gov/35704396
Autor:
Heba N. Altarawneh, Hiam Chemaitelly, Houssein Ayoub, Patrick Tang, Mohammad R. Hasan, HADI M. YASSINE, Hebah A. Al-Khatib, Maria K. Smatti, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J Abu-Raddad
BACKGROUND: Protection offered by five different forms of immunity, combining natural and vaccine immunity, was investigated against SARS-CoV-2 Omicron symptomatic BA.1 infection, symptomatic BA.2 infection, BA.1 hospitalization and death, and BA.2 h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebf909dd1f3ebe6bfa0155a49dd0b4ef
https://doi.org/10.1101/2022.03.22.22272745
https://doi.org/10.1101/2022.03.22.22272745